13 results
Ivermectin. Old anti-parasitic agent making a comeback with recent headlines from in-vitro study that showed antiviral
virus causing COVID ... SARS-CoV-2 #Pandemic #Outbreak ... InfectiousDiseases #CriticalCare ... EmergencyMedicine #Pharmacology ... Virus #Antiviral #Management
Graded Oxygen Administration in COVID-19

#respiratory #support #COVID19 #management #schema #criticalcare #hypoxia #failure #algorithm #coronavirus #sarscov2 #oxygen
Administration in COVID ... respiratory #support #COVID19 ... #management #schema ... #criticalcare #
COVID-19 review…here is a list of some of the drugs that are currently being used or
COVID-19 review… ... CoronaVirus #Treatment #Management ... #Pandemic #Outbreak ... Pharmacotherapy #Pharmacology ... #CriticalCare #
COVID-19 Hypoxia Management

Indication for endotracheal intubation?
Tolerating supplemental oxygen?
Consider HFNC
Not tolerating HFNC or HFNC is not available?
Consider
COVID-19 Hypoxia ... Management Indication ... respiratory #support #COVID19 ... #management #schema ... #criticalcare #
Running out of Analgesia and Sedation Medications due to #COVID19?  Anand Swaminathan, MD has put
Medications due to #COVID19 ... Medications #management ... #covid19 #treatment ... #sarscov2 #criticalcare ... sedative #analgesia #pharmacology
Proposed Respiratory Support Algorithm in COVID19

The ‘intubate early’ paradigm, where patients who “fail” low flow oxygen
Support Algorithm in COVID19 ... patients with COVID ... respiratory #support #COVID19 ... #management #schema ... #criticalcare #
General schema for respiratory support in patients with COVID-19
Low flow nasal cannula
 • Typically set at
General schema for ... patients with COVID ... respiratory #support #COVID19 ... #management #schema ... #criticalcare #
Drugs Used for the Treatment of COVID-19 Infection

** Editor Note (from ophthalmology MD input) - Hydroxychloroquine/chloroquine
the Treatment of COVID ... Hydroxychloroquine/chloroquine should ... macular pathology" should ... #Pharmacology # ... Table #Management
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
Siltuximab) in COVID19 ... Total dose should ... Tocilizumab should ... #Pharmacology # ... Management #Medications
Possible Approach to Immunosuppression in Severe COVID-19

The diagnosis and treatment of cytokine storm remains unknown and
Immunosuppression in Severe COVID ... treatment decisions should ... anticoagulation #COVID19 ... #management #schema ... #criticalcare #